Position 5-7: Finalization

Pericardial Cavity

Select the specific approach and device combination to identify the exact billable procedure code.

Approach 3

Percutaneous

Device 0

3E0Y304 Introduction Pericardial Cavity to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach
3E0Y305 Introduction Pericardial Cavity to Other Antineoplastic with Antineoplastic, Percutaneous Approach
3E0Y30M Introduction Pericardial Cavity to Monoclonal Antibody with Antineoplastic, Percutaneous Approach

Device 2

3E0Y328 Introduction Pericardial Cavity to Oxazolidinones with Anti-infective, Percutaneous Approach
3E0Y329 Introduction Pericardial Cavity to Other Anti-infective with Anti-infective, Percutaneous Approach

Device 3

3E0Y33Z Introduction Pericardial Cavity to No Qualifier with Anti-inflammatory, Percutaneous Approach

Device 6

3E0Y36Z Introduction Pericardial Cavity to No Qualifier with Nutritional Substance, Percutaneous Approach

Device 7

3E0Y37Z Introduction Pericardial Cavity to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach

Device B

3E0Y3BZ Introduction Pericardial Cavity to No Qualifier with Anesthetic Agent, Percutaneous Approach

Device G

3E0Y3GC Introduction Pericardial Cavity to Other Substance with Other Therapeutic Substance, Percutaneous Approach

Device H

3E0Y3HZ Introduction Pericardial Cavity to No Qualifier with Radioactive Substance, Percutaneous Approach

Device K

3E0Y3KZ Introduction Pericardial Cavity to No Qualifier with Other Diagnostic Substance, Percutaneous Approach

Device N

3E0Y3NZ Introduction Pericardial Cavity to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach

Device S

3E0Y3SF Introduction Pericardial Cavity to Other Gas with Gas, Percutaneous Approach

Device T

3E0Y3TZ Introduction Pericardial Cavity to No Qualifier with Destructive Agent, Percutaneous Approach
Approach 4

Percutaneous Endoscopic

Device G

3E0Y4GC Introduction Pericardial Cavity to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach
Approach 7

Via Natural or Artificial Opening

Device 0

3E0Y704 Introduction Pericardial Cavity to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach
3E0Y705 Introduction Pericardial Cavity to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach
3E0Y70M Introduction Pericardial Cavity to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach

Device S

3E0Y7SF Introduction Pericardial Cavity to Other Gas with Gas, Via Natural or Artificial Opening Approach